Qiumeng Liu

机构：Tongji Hospital, Huazhong University of Science and Technology

发表论文 42 篇 · 总被引 1099 次 · h-index 20

代表论文

• YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis (2024 · Advanced Science · 被引 71)
• DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6 (2022 · Oncogene · 被引 65)
• Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation (2024 · 癌症：英文版 · 被引 54)
• The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease (2023 · International Journal of Biological Sciences · 被引 51)
• Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti–PD-1 resistance in hepatocellular carcinoma (2025 · Science Immunology · 被引 41)
• TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway (2025 · Journal of Hepatology · 被引 32)